Response to McMullan et al, "Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy," and Yaghi et al., "Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation"

J Am Acad Dermatol. 2024 Aug;91(2):e33-e34. doi: 10.1016/j.jaad.2024.03.045. Epub 2024 Apr 12.
No abstract available

Keywords: lactation; maternal-fetal medicine; multidisciplinary care; pregnancy; rituximab; safety.

Publication types

  • Letter

MeSH terms

  • Breast Feeding
  • Dermatologic Agents* / adverse effects
  • Dermatologic Agents* / therapeutic use
  • Female
  • Humans
  • Lactation* / drug effects
  • Pregnancy
  • Pregnancy Complications / drug therapy

Substances

  • Dermatologic Agents